Idiopathic catatonia

disease
On this page

Summary

Idiopathic catatonia (MONDO:0957487) is a disease. A subtype of catatonia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 16

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families16WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

16 HPO clinical features (Orphanet curated; top 16 by frequency):

HPO IDTermFrequency
HP:0000273Facial grimacingFrequent (30-79%)
HP:0000713AgitationFrequent (30-79%)
HP:0000733Abnormal repetitive mannerismsFrequent (30-79%)
HP:0001259ComaFrequent (30-79%)
HP:0002039AnorexiaFrequent (30-79%)
HP:0002300MutismFrequent (30-79%)
HP:0002533Abnormal posturingFrequent (30-79%)
HP:0007302Bipolar affective disorderFrequent (30-79%)
HP:0010529EcholaliaFrequent (30-79%)
HP:0100753SchizophreniaFrequent (30-79%)
HP:0410291NegativismFrequent (30-79%)
HP:0000752HyperactivityOccasional (5-29%)
HP:0002396Cogwheel rigidityOccasional (5-29%)
HP:0025401Staring gazeOccasional (5-29%)
HP:0030903Grasp reflexOccasional (5-29%)
HP:0100710ImpulsivityOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical nameidiopathic catatonia
Mondo IDMONDO:0957487
Orphanet648919
UMLSC5816742
MedGen1843416
GARD0026851
Is cancer (heuristic)no

Disease family

This is a subtype of catatonia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disordercatatoniaidiopathic catatonia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.